Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Indian cancer patients battle shortage of key drugs as platinum costs surge
Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues are causing shortages. This forces patients to search extensively for medication. Some drugmakers have reduced production. The situation puts immense pressure on the healthcare system and patients seeking treatment.
Bernstein bets on Indian healthcare, sees these three stocks as key beneficiaries
According to Bernstein, valuations across the Indian biopharma sector have re-rated significantly, with the Nifty Pharma index trading slightly above its 10-year average multiple of 30.5 times its one-year forward earnings. However, it noted that its preferred stocks continue to trade below their long-term average valuations.
Top stocks to buy today: Anand James of Geojit bets on theses 3 shares
Anand James, chief market strategist at Geojit Investments, is bullish on the shares of Jindal Steel, SJS Enterprises, and Fortis Healthcare today
Five Stocks To Buy: ICICI Bank, Bharti Airtel, Fortis Healthcare And More | June 09, 2026
Top picks include private sector lenders ICICI Bank and Federal Bank, telecom giant Bharti Airtel, and hospital chain Fortis Healthcare.
Truist cuts Omega Healthcare stock price target on valuation By Investing.com - Investing.com India
Truist cuts Omega Healthcare stock price target on valuation By Investing.comInvesting.com India
Haleon to invest Rs 2,000 crore to set up first India plant
Haleon is investing Rs 2,000 crore to build its first manufacturing plant in Pithampur, India. This move sharpens its focus on India, a fast-growing consumer healthcare market. The plant will produce oral-health products, including Sensodyne. It aims to reach one billion more consumers by 2030, with 300 million in India. The facility will also cater to export markets.
Here is the one sector bucking the trend in a weak market; Check out top gainers
Five among the top 10 gainers on the Nifty 500 index are Pharma stocks. They include Pfizer (Up 4.6%), Anthem Biosciences (Up 2.5%), Syngene (Up 2%), Aster DM Healthcare (Up 2%) and Wockhardt (Up 2%).
Analysts lift bets on India Inc after strong March quarter
Analysts have upgraded earnings estimates for a majority of NSE 500 companies following better-than-expected profit growth in the March 2026 quarter. This surge in upgrades, particularly for sectors like banking, capital goods, and healthcare, is driven by strong performance and favorable market conditions. The quantum of earnings revisions also saw a significant increase, with many companies receiving substantial upward adjustments.
Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for supply
Uzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbekistan a key hub for making and supplying medicines in the region. Simplified rules and tax benefits will encourage more investment. This move will boost local healthcare and strengthen trade ties between the two nations.
Upcoming IPO? Paras Healthcare Files Draft Papers With SEBI To Raise Rs 1,800 Crore Via IPO
Paras Healthcare IPO: The total offer size is up to Rs 1,800 crore.
CMR Green IPO subscribed 127x; Paras Healthcare files for ₹1,800-cr IPO
CMR Green's IPO was subscribed 127 times, boosting hopes of a primary market revival as Sebi cleared five new IPOs and Paras Healthcare filed draft papers
Sensex sheds 117 points after RBI policy; healthcare stocks buck trend
The S&P BSE Sensex declined 116.67 points or 0.16% to 74,243.34. The Nifty 50 index slipped 49.85 points or 0.21% to 23,366.70.